Bevacizumab in the treatment of colorectal cancer.
作者信息
Marshall John L
机构信息
Division ofHematology/Oncology, Georgetown University Medical Center, Washington, DC, USA.
出版信息
Clin Adv Hematol Oncol. 2007 Jan;5(1 Suppl 1):8-9.
PMID:17491585
Abstract
摘要
相似文献
1
Bevacizumab in the treatment of colorectal cancer.
Clin Adv Hematol Oncol. 2007 Jan;5(1 Suppl 1):8-9.
2
Liver resection after FOLFOX with bevacizumab.
Clin Adv Hematol Oncol. 2007 Jan;5(1 Suppl 1):12-4.
3
Perforating dermatosis in a patient receiving bevacizumab.
J Eur Acad Dermatol Venereol. 2009 Aug;23(8):972-4. doi: 10.1111/j.1468-3083.2008.03078.x. Epub 2009 Mar 17.
4
Current role of bevacizumab in colorectal cancer.
Clin Adv Hematol Oncol. 2009 Jun;7(6):375-6.
5
The use cetuximab after oxaliplatin-based chemotherapy in a patient with metastatic colorectal cancer.
Clin Adv Hematol Oncol. 2007 Jan;5(1 Suppl 1):4-7.
6
Accrual delayed in adjuvant bevacizumab trial.
J Natl Cancer Inst. 2006 Apr 5;98(7):439-40. doi: 10.1093/jnci/djj148.
7
Update: NCCN colon and rectal cancer clinical practice guidelines.
J Natl Compr Canc Netw. 2004 Sep;2 Suppl 3:S-14-8.
8
First description of an uterine perforation potentially imputable to treatment with bevacizumab.
Acta Oncol. 2012 Nov;51(8):1102-4. doi: 10.3109/0284186X.2012.689855. Epub 2012 Oct 1.
9
Late anastomotic dehiscence during bevacizumab therapy for patients with colorectal cancer.
Clin Oncol (R Coll Radiol). 2011 Sep;23(7):497-8. doi: 10.1016/j.clon.2011.03.009. Epub 2011 May 14.
10
[Advances in the treatment of metastatic colorectal cancer with bevacizumab].
Tumori. 2006 Sep-Oct;92(5):suppl 1-12.
引用本文的文献
1
A Prospective Study to Evaluate Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma.
Ophthalmol Ther. 2015 Jun;4(1):33-41. doi: 10.1007/s40123-015-0033-3. Epub 2015 Mar 27.
Zotero 插件